This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Natarajan, R. Articles by Bai, W. Search for Related Content PubMed PubMed Citation Articles by Natarajan, R. Articles by Bai, W.

(Hypertension. 1997;30:873-879.)
© 1997 American Heart Association, Inc.

Articles

Regulation of 12-Lipoxygenase by Cytokines in Vascular Smooth Muscle Cells

Rama Natarajan; Jullia Rosdahl; Noe Gonzales; ; Wei Bai

From the Department of Diabetes and Endocrinology, City of Hope Medical Center, Duarte, Calif.

Correspondence to Rama Natarajan, PhD, Department of Diabetes and Endocrinology, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010. E-mail rnatarajan{at}smtplink.coh.org

Abstract Increasing evidence suggests that cytokines such as interleukin-1ß (IL-1), IL-4, and IL-8 may play an important role in the chronic inflammation and cellular growth observed in cardiovascular diseases. The lipoxygenase (LO) pathway of arachidonate metabolism has also been related to the pathology of hypertension and atherosclerosis. LO products have chemotactic, hypertrophic, and mitogenic effects in vascular cells, and the LO enzyme has been implicated in the oxidation of LDL. Furthermore, earlier studies have shown that vascular smooth muscle cell (VSMC) growth factors such as angiotensin II and platelet-derived growth factor can increase LO activity and expression in VSMCs. In the present study, we have examined whether vasoactive and inflammatory cytokines such as IL-1, IL-4, and IL-8 can modulate 12-LO activity and expression in porcine VSMCs and also whether they have growth-promoting effects in these cells. Treatment of porcine VSMCs with these cytokines led to significant increases in the levels of a cell-associated 12-LO product, 12-hydroxyeicosatetraenoic acid, as well as intracellular 12-LO enzyme activity. Furthermore, each of these cytokines led to a dose-dependent increase in 12-LO mRNA expression (333-base pair PCR product) as well as 12-LO protein expression (72 kD). In addition, all three interleukins could induce significant increases in VSMC DNA synthesis as well as proliferation. These results suggest that these cytokines have mitogenic effects in VSMCs and are also potent positive regulators of the 12-LO pathway. Thus, enhanced 12-LO activity and expression may be a key mechanism for cytokine-induced VSMC migration and proliferation.

Key Words: 12-lipoxygenase • muscle, smooth • interleukin

This article has been cited by other articles:

				I. R. Preston, N. S. Hill, R. R. Warburton, and B. L. Fanburg Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L367 - L374. [Abstract] [Full Text] [PDF]

				A. M. Taylor, R. Hanchett, R. Natarajan, C. C. Hedrick, S. Forrest, J. L. Nadler, and C. A. McNamara The Effects of Leukocyte-Type 12/15-Lipoxygenase on Id3-Mediated Vascular Smooth Muscle Cell Growth Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2069 - 2074. [Abstract] [Full Text] [PDF]

				R. Natarajan and J. L. Nadler Lipid Inflammatory Mediators in Diabetic Vascular Disease Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1542 - 1548. [Abstract] [Full Text] [PDF]

				H. Kosuge, J.-i. Suzuki, T. Kakuta, G. Haraguchi, N. Koga, H. Futamatsu, R. Gotoh, M. Inobe, M. Isobe, and T. Uede Attenuation of Graft Arterial Disease by Manipulation of the LIGHT Pathway Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1409 - 1415. [Abstract] [Full Text] [PDF]

				J. R. Kizer, D. A. Zisman, N. P. Blumenthal, R. M. Kotloff, S. E. Kimmel, R. M. Strieter, S. M. Arcasoy, V. A. Ferrari, and J. Hansen-Flaschen Association Between Pulmonary Fibrosis and Coronary Artery Disease Arch Intern Med, March 8, 2004; 164(5): 551 - 556. [Abstract] [Full Text] [PDF]

				S. S. Yiu, X. Zhao, E. W. Inscho, and J. D. Imig 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels J. Lipid Res., December 1, 2003; 44(12): 2391 - 2399. [Abstract] [Full Text] [PDF]

				M. A. Reddy, Y.-S. Kim, L. Lanting, and R. Natarajan Reduced Growth Factor Responses in Vascular Smooth Muscle Cells Derived from 12/15-Lipoxygenase-Deficient Mice Hypertension, June 1, 2003; 41(6): 1294 - 1300. [Abstract] [Full Text] [PDF]

				M. A. Reddy, P.-R. Thimmalapura, L. Lanting, J. L. Nadler, S. Fatima, and R. Natarajan The Oxidized Lipid and Lipoxygenase Product 12(S)-Hydroxyeicosatetraenoic Acid Induces Hypertrophy and Fibronectin Transcription in Vascular Smooth Muscle Cells via p38 MAPK and cAMP Response Element-binding Protein Activation. MEDIATION OF ANGIOTENSIN II EFFECTS J. Biol. Chem., March 15, 2002; 277(12): 9920 - 9928. [Abstract] [Full Text] [PDF]

				B. C. Y. Wong, W. P. Wang, C. H. Cho, X. M. Fan, M. C. M. Lin, H. F. Kung, and S. K. Lam 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells Carcinogenesis, September 1, 2001; 22(9): 1349 - 1354. [Abstract] [Full Text] [PDF]

				R. A. Stockton and B. S. Jacobson Modulation of Cell-Substrate Adhesion by Arachidonic Acid: Lipoxygenase Regulates Cell Spreading and ERK1/2-inducible Cyclooxygenase Regulates Cell Migration in NIH-3T3 Fibroblasts Mol. Biol. Cell, July 1, 2001; 12(7): 1937 - 1956. [Abstract] [Full Text] [PDF]

				J.-L. Gu, H. Pei, L. Thomas, J. L. Nadler, J. J. Rossi, L. Lanting, and R. Natarajan Ribozyme-Mediated Inhibition of Rat Leukocyte-Type 12-Lipoxygenase Prevents Intimal Hyperplasia in Balloon-Injured Rat Carotid Arteries Circulation, March 13, 2001; 103(10): 1446 - 1452. [Abstract] [Full Text] [PDF]

				F. Stanke-Labesque, P. Devillier, S. Veitl, F. Caron, J.-L. Cracowski, and G. Bessard Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats Cardiovasc Res, January 1, 2001; 49(1): 152 - 160. [Abstract] [Full Text] [PDF]

				M. Hou, S. Moller, L. Edvinsson, and D. Erlinge Cytokines Induce Upregulation of Vascular P2Y2 Receptors and Increased Mitogenic Responses to UTP and ATP Arterioscler Thromb Vasc Biol, September 1, 2000; 20(9): 2064 - 2069. [Abstract] [Full Text] [PDF]

				L. H. Wei, A. T. Jacobs, S. M. Morris Jr., and L. J. Ignarro IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells Am J Physiol Cell Physiol, July 1, 2000; 279(1): C248 - C256. [Abstract] [Full Text] [PDF]

				R. Natarajan, H. Pei, J.-L. Gu, J. M. Sarma, and J. Nadler Evidence for 12-lipoxygenase induction in the vessel wall following balloon injury Cardiovasc Res, February 1, 1999; 41(2): 489 - 499. [Abstract] [Full Text] [PDF]

				M. K. Patricia, R. Natarajan, A. N. Dooley, F. Hernandez, J.-L. Gu, J. A. Berliner, J. J. Rossi, J. L. Nadler, R. S. Meidell, and C. C. Hedrick Adenoviral Delivery of a Leukocyte-Type 12 Lipoxygenase Ribozyme Inhibits Effects of Glucose and Platelet-Derived Growth Factor in Vascular Endothelial and Smooth Muscle Cells Circ. Res., April 13, 2001; 88(7): 659 - 665. [Abstract] [Full Text] [PDF]